191 related articles for article (PubMed ID: 27597281)
1. Microenvironmental changes in the progression from adenocarcinoma in situ to minimally invasive adenocarcinoma and invasive lepidic predominant adenocarcinoma of the lung.
Naito M; Aokage K; Saruwatari K; Hisakane K; Miyoshi T; Hishida T; Yoshida J; Masato S; Kojima M; Kuwata T; Fujii S; Ochiai A; Sato Y; Tsuboi M; Ishii G
Lung Cancer; 2016 Oct; 100():53-62. PubMed ID: 27597281
[TBL] [Abstract][Full Text] [Related]
2. Aggressive tumor microenvironment of solid predominant lung adenocarcinoma subtype harboring with epidermal growth factor receptor mutations.
Saruwatari K; Ikemura S; Sekihara K; Kuwata T; Fujii S; Umemura S; Kirita K; Matsumoto S; Yoh K; Niho S; Ohmatsu H; Ochiai A; Kohrogi H; Tsuboi M; Goto K; Ishii G
Lung Cancer; 2016 Jan; 91():7-14. PubMed ID: 26711928
[TBL] [Abstract][Full Text] [Related]
3. Expression of CLDN1 and CLDN10 in lung adenocarcinoma in situ and invasive lepidic predominant adenocarcinoma.
Zhang Z; Wang A; Sun B; Zhan Z; Chen K; Wang C
J Cardiothorac Surg; 2013 Apr; 8():95. PubMed ID: 23591077
[TBL] [Abstract][Full Text] [Related]
4. The difference in Ezrin-pAkt signaling axis between lepidic and papillary predominant invasive adenocarcinomas of the lung.
Hata K; Yoshida J; Udagawa H; Hashimoto H; Fujii S; Hishida T; Kuwata T; Aokage K; Kojima M; Ochiai A; Suzuki K; Tsuboi M; Ishii G
J Cancer Res Clin Oncol; 2016 Jul; 142(7):1421-30. PubMed ID: 27059464
[TBL] [Abstract][Full Text] [Related]
5. Predictors of Invasiveness in Adenocarcinoma of Lung with Lepidic Growth Pattern.
Young TJ; Salehi-Rad R; Ronaghi R; Yanagawa J; Shahrouki P; Villegas BE; Cone B; Fishbein GA; Wallace WD; Abtin F; Barjaktarevic I
Med Sci (Basel); 2022 Jun; 10(3):. PubMed ID: 35893116
[TBL] [Abstract][Full Text] [Related]
6. Significance of interstitial tumor-associated macrophages in the progression of lung adenocarcinoma.
Sun BS; Pei BX; Zhang K; Zhang LC; Zhang GJ; Liu JK; Cui HW; Pan F; Zhang ZF
Oncol Lett; 2016 Dec; 12(6):4467-4476. PubMed ID: 28101209
[TBL] [Abstract][Full Text] [Related]
7. Differences of tumor microenvironment between stage I lepidic-positive and lepidic-negative lung adenocarcinomas.
Katsumata S; Aokage K; Miyoshi T; Tane K; Nakamura H; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Hayashi R; Tsuboi M; Ishii G
J Thorac Cardiovasc Surg; 2018 Oct; 156(4):1679-1688.e2. PubMed ID: 30257286
[TBL] [Abstract][Full Text] [Related]
8. Early lung cancer with lepidic pattern: adenocarcinoma in situ, minimally invasive adenocarcinoma, and lepidic predominant adenocarcinoma.
Weichert W; Warth A
Curr Opin Pulm Med; 2014 Jul; 20(4):309-16. PubMed ID: 24811831
[TBL] [Abstract][Full Text] [Related]
9. Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
Behera M; Owonikoko TK; Gal AA; Steuer CE; Kim S; Pillai RN; Khuri FR; Ramalingam SS; Sica GL
Clin Lung Cancer; 2016 Sep; 17(5):e57-e64. PubMed ID: 27137345
[TBL] [Abstract][Full Text] [Related]
10. A proteogenomic profile of early lung adenocarcinomas by protein co-expression network and genomic alteration analysis.
Nishimura T; Nakamura H; Tan KT; Zhuo DW; Fujii K; Koizumi H; Naruki S; Takagi M; Furuya N; Kato Y; Chen SJ; Kato H; Saji H
Sci Rep; 2020 Aug; 10(1):13604. PubMed ID: 32788598
[TBL] [Abstract][Full Text] [Related]
11. Distinctive clinicopathological features of adenocarcinoma in situ and minimally invasive adenocarcinoma of the lung: A retrospective study.
Ishida H; Shimizu Y; Sakaguchi H; Nitanda H; Kaneko K; Yamazaki N; Yanagihara A; Taguchi R; Sakai F; Yasuda M; Kobayashi K
Lung Cancer; 2019 Mar; 129():16-21. PubMed ID: 30797486
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma in situ, minimally invasive adenocarcinoma, and invasive pulmonary adenocarcinoma--analysis of interobserver agreement, survival, radiographic characteristics, and gross pathology in 296 nodules.
Boland JM; Froemming AT; Wampfler JA; Maldonado F; Peikert T; Hyland C; de Andrade M; Aubry MC; Yang P; Yi ES
Hum Pathol; 2016 May; 51():41-50. PubMed ID: 27067781
[TBL] [Abstract][Full Text] [Related]
13. Link between tumor-promoting fibrous microenvironment and an immunosuppressive microenvironment in stage I lung adenocarcinoma.
Sakai T; Aokage K; Neri S; Nakamura H; Nomura S; Tane K; Miyoshi T; Sugano M; Kojima M; Fujii S; Kuwata T; Ochiai A; Iyoda A; Tsuboi M; Ishii G
Lung Cancer; 2018 Dec; 126():64-71. PubMed ID: 30527194
[TBL] [Abstract][Full Text] [Related]
14. Abundant tumor promoting stromal cells in lung adenocarcinoma with hypoxic regions.
Nakamura H; Ichikawa T; Nakasone S; Miyoshi T; Sugano M; Kojima M; Fujii S; Ochiai A; Kuwata T; Aokage K; Suzuki K; Tsuboi M; Ishii G
Lung Cancer; 2018 Jan; 115():56-63. PubMed ID: 29290263
[TBL] [Abstract][Full Text] [Related]
15. The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer.
Travis WD; Asamura H; Bankier AA; Beasley MB; Detterbeck F; Flieder DB; Goo JM; MacMahon H; Naidich D; Nicholson AG; Powell CA; Prokop M; Rami-Porta R; Rusch V; van Schil P; Yatabe Y;
J Thorac Oncol; 2016 Aug; 11(8):1204-1223. PubMed ID: 27107787
[TBL] [Abstract][Full Text] [Related]
16. HRCT texture analysis for pure or part-solid ground-glass nodules: distinguishability of adenocarcinoma in situ or minimally invasive adenocarcinoma from invasive adenocarcinoma.
Yagi T; Yamazaki M; Ohashi R; Ogawa R; Ishikawa H; Yoshimura N; Tsuchida M; Ajioka Y; Aoyama H
Jpn J Radiol; 2018 Feb; 36(2):113-121. PubMed ID: 29273964
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of adenocarcinoma in situ, minimally invasive adenocarcinoma, and nonmucinous lepidic predominant invasive adenocarcinoma of the lung in patients with stage I disease.
Kadota K; Villena-Vargas J; Yoshizawa A; Motoi N; Sima CS; Riely GJ; Rusch VW; Adusumilli PS; Travis WD
Am J Surg Pathol; 2014 Apr; 38(4):448-60. PubMed ID: 24472852
[TBL] [Abstract][Full Text] [Related]
18. What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology?
Aherne EA; Plodkowski AJ; Montecalvo J; Hayan S; Zheng J; Capanu M; Adusumilli PS; Travis WD; Ginsberg MS
Lung Cancer; 2018 Apr; 118():83-89. PubMed ID: 29572008
[TBL] [Abstract][Full Text] [Related]
19. The percentage of lepidic growth is an independent prognostic factor in invasive adenocarcinoma of the lung.
Strand TE; Rostad H; Strøm EH; Hasleton P
Diagn Pathol; 2015 Jul; 10():94. PubMed ID: 26159539
[TBL] [Abstract][Full Text] [Related]
20. Tumor-associated macrophages promote Ezrin phosphorylation-mediated epithelial-mesenchymal transition in lung adenocarcinoma through FUT4/LeY up-regulation.
Wang A; Lu C; Ning Z; Gao W; Xie Y; Zhang N; Liang J; Abbasi FS; Yan Q; Liu J
Oncotarget; 2017 Apr; 8(17):28247-28259. PubMed ID: 28423676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]